-
Health Advisory: King County measles case traveled through SeaTac airport
Advisory or Update, Communicable Disease and Immunization Update, Health Advisory, Health Alert, Immunization, Immunizations, Measles, News and Alerts, News and Update, Notifiable Conditions, Provider Resources, Travel, VaccineActions Requested Background Current situation Seattle King County Public Health is investigating a local case of measles in an adult who was exposed while overseas. The case was at SeaTac airport and Providence Swedish First Hill Emergency Department during their infectious period before receiving the diagnosis of measles. The case did not wear a face … Health Advisory: King County measles case traveled through SeaTac airport
-
Health Advisory: CDC updated antiviral guidance
Advisory or Update, Communicable Disease and Immunization Update, COVID-19, Health Advisory, Health Alert, Immunization, News and Alerts, News and Update, Notifiable Conditions, Novel Coronavirus, Provider Resources, SchoolsActions Requested Be aware, Centers for Disease Control and Prevention (CDC) updated its COVID-19 monoclonal antibody treatment recommendations. Sotrovimab monoclonal antibody formulation retains significant efficacy against Omicron, the dominant circulating variant. Other monoclonal antibody formulations under emergency use authorization (EUA)—bamlanivimab and etesevimab and casirivimab and imdevimab—lack clinical benefit against Omicron and should not be used … Health Advisory: CDC updated antiviral guidance
-
01/06/22 Health Advisory: Booster Eligibility Expanded
Advisory or Update, Communicable Disease and Immunization Update, COVID-19, Health Advisory, Immunizations, News and Alerts, Notifiable Conditions, Provider ResourcesCOVID-19 Updates for Providers Requested actions Be aware, Centers for Disease Control and Prevention (CDC) endorsed Advisory Committee on Immunization Practices’ (ACIP’s) decision to strongly recommend a single Pfizer COVID-19 vaccine booster dose for people 12–17 years old at least 5 months after their primary series. This expands the age of booster access and strengthens … 01/06/22 Health Advisory: Booster Eligibility Expanded
-
01/04/22 Health Advisory: CDC updated antiviral guidance
Advisory or Update, COVID-19, Health Advisory, News and Alerts, Notifiable Conditions, Provider ResourcesCOVID-19 Updates for Providers Requested actions Be aware, Centers for Disease Control and Prevention (CDC) updated its COVID-19 monoclonal antibody treatment recommendations. Sotrovimab monoclonal antibody formulation retains significant efficacy against Omicron, the dominant circulating variant. Other monoclonal antibody formulations under emergency use authorization (EUA)—bamlanivimab and etesevimab and casirivimab and imdevimab—lack clinical benefit against Omicron and … 01/04/22 Health Advisory: CDC updated antiviral guidance
-
Kitsap Respiratory Illness Report December 19 – December 25, 2021
Click here to access the latest Kitsap Respiratory Illness Report: 12.19.21 – 12.25.21.
-
Health Advisory: COVID-19 Updates for Providers – New I&Q Guidance, FDA grants EUA to Molnupiravir
COVID-19, Emerging Diseases and Conditions, Health Advisory, Health Alert, Infection Control, News and AlertsActions Requested Be aware, Centers for Disease Control and Prevention (CDC) issued new isolation and quarantine (I&Q) guidance for healthcare workers (HCWs). The guidance is complex and varies based on vaccination status, level of exposure and level of crisis in the community. Carefully review the new guidance for details. Following exposure, CDC recommends: Boosted HCWs … Health Advisory: COVID-19 Updates for Providers – New I&Q Guidance, FDA grants EUA to Molnupiravir
-
Health Advisory: Paxlovid Granted EUA and Testing Before Gathering
Advisory or Update, Communicable Disease and Immunization Update, COVID-19, Emerging Diseases and Conditions, Health Advisory, Health Alert, Immunization, Immunizations, Infection Control, News and Alerts, News and Update, Notifiable Conditions, Novel Coronavirus, Prevention, Provider Resources, Schools, Travel, VaccineActions Requested Be aware, Food and Drug Administration (FDA) granted emergency use authorization (EUA) to the first oral antiviral treatment for COVID-19, Pfizer’s Paxlovid. The EUA comes after research showed Paxlovid was nearly 90% effective at preventing hospitalization and death in people 12 years or older at high risk of severe outcomes within 5 days … Health Advisory: Paxlovid Granted EUA and Testing Before Gathering
-
Health Advisory: Updated J&J Vaccine Recommendations
Requested actions Be aware, on December 16, Centers for Disease Control and Prevention (CDC) recommended mRNA COVID-19 vaccines (Pfizer or Moderna) over Johnson & Johnson (J&J) COVID-19 vaccine for all people 18 years or older. The recommendation is based on the increased risk of thrombosis with thrombocytopenia syndrome (TTS) after getting J&J COVID-19 vaccine. Be … Health Advisory: Updated J&J Vaccine Recommendations
-
Kitsap Respiratory Illness Report December 5 – December 11, 2021
Click here to access the latest Kitsap Respiratory Illness Report: 12.5.21 – 12.11.21.
-
Health Advisory: COVID-19 UPDATES – BOOSTERS, EVUSHELD, and OMICRON VARIANT
Advisory or Update, COVID-19, Health Advisory, Health Alert, News and Alerts, News and Update, VaccineActions Requested Be aware, Centers for Disease Control and Prevention (CDC) and Western States Scientific Safety Review Workgroup recommend everyone 16 years or older get a COVID-19 vaccine booster dose at the recommended interval. This recommendation comes after Food and Drug Administration (FDA) expanded its emergency use authorization (EUA) for Pfizer-BioNTech COVID-19 vaccine booster doses … Health Advisory: COVID-19 UPDATES – BOOSTERS, EVUSHELD, and OMICRON VARIANT
-
Health Advisory: COVID-19 Updates – Omicron Variant, Multisystem Inflammatory Syndrome, and Vaccination
Advisory or Update, Communicable Disease and Immunization Update, COVID-19, Health Advisory, Immunizations, News and Alerts, News and Update, Provider Resources, Schools, VaccineRequested actions Be aware of quickly evolving information about the new SARS-CoV-2 variant, Omicron. CDC Health Alert Network (HAN) Advisory SARS-CoV-2 Variant of Concern Identified: Omicron (B.1.1.529) Variant, 11pm on December 1, 2021 CDC Science Brief: Omicron (B1.1.529) Variant, last updated December 2, 2021 GISAID international variant tracking data and maps Consider Omicron as part of your … Health Advisory: COVID-19 Updates – Omicron Variant, Multisystem Inflammatory Syndrome, and Vaccination
-
Health Advisory: Opportunity to Participate in a Medication for Opioid Use Disorder (MOUD) Learning Collaborative
Actions Requested: Consider participating in a Medication for Opioid Use Disorder (MOUD) in Primary Care Learning Collaborative. The learning collaborative will address both best clinical practices and developing clinical systems to support an MOUD program in a primary care clinic setting. The opportunity is open to healthcare organizations who want to begin offering MOUD treatment … Health Advisory: Opportunity to Participate in a Medication for Opioid Use Disorder (MOUD) Learning Collaborative
-
Kitsap Respiratory Illness Report November 7 – November 13, 2021
Click here to access the latest Kitsap Respiratory Illness Report: 11.7.21 – 11.13.21.